CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Switching to ocrelizumab in RRMS patients at risk of PML previously treated with extended interval dosing of natalizumab
Author
Chiara Rosa Mancinelli
Cinzia Cordioli
+8Â more
Cristina Scarpazza
Ho P-R
Maria Vittoria Turrini
Nicola De Rossi
Ruggero Capra
Sarah Rasia
Smoot K
Zhovtis Ryrson L
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref